Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2002 2
2003 1
2004 1
2005 1
2006 2
2007 1
2009 1
2011 1
2012 1
2013 3
2014 5
2015 2
2016 4
2017 4
2018 4
2019 1
2020 8
2021 10
2022 8
2023 8
2024 5
2025 6
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69).
Nelson-Piercy C, Dean C, Shehmar M, Gadsby R, O'Hara M, Hodson K, Nana M; Royal College of Obstetricians and Gynaecologists. Nelson-Piercy C, et al. BJOG. 2024 Jun;131(7):e1-e30. doi: 10.1111/1471-0528.17739. Epub 2024 Feb 4. BJOG. 2024. PMID: 38311315
[Grade A] There is evidence that ondansetron is safe and effective. Its use as a second line antiemetic should not be discouraged if first line antiemetics are ineffective. ...[Grade D] All therapeutic measures should have been tried before considering termination of pr …
[Grade A] There is evidence that ondansetron is safe and effective. Its use as a second line antiemetic should not be discouraged if …
Efficacy and safety of ondansetron for morning sickness in pregnancy: a systematic review of clinical trials.
Ashour AM. Ashour AM. Front Pharmacol. 2023 Oct 23;14:1291235. doi: 10.3389/fphar.2023.1291235. eCollection 2023. Front Pharmacol. 2023. PMID: 37936910 Free PMC article.
Therefore, we aimed to identify and provide details of the efficacy and safety of ondansetron in clinical trials. Methods: A search was conducted of the ClinicalTrials.gov database on 13 April 2023, using the search term "ondansetron and pregnancy." .. …
Therefore, we aimed to identify and provide details of the efficacy and safety of ondansetron in clinical trials. Methods: A s …
Hyperemesis in Pregnancy: Complications and Treatment.
Gerede A, Stavros S, Moustakli E, Potiris A, Orgianelis I, Zikopoulos A, Drakakis P, Domali E, Eleutheriades M, Nikolettos N. Gerede A, et al. Med Sci (Basel). 2025 Aug 14;13(3):132. doi: 10.3390/medsci13030132. Med Sci (Basel). 2025. PMID: 40843754 Free PMC article. Review.
BACKGROUND: Hyperemesis gravidarum (HG) is the leading cause of hospitalization during early pregnancy, affecting approximately 0.3-3% of pregnancies. It represents the most severe end of the nausea and vomiting in pregnancy (NVP) spectrum and is associated w …
BACKGROUND: Hyperemesis gravidarum (HG) is the leading cause of hospitalization during early pregnancy, affecting approximately 0.3-3 …
Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence.
Mansour O, Russo RG, Straub L, Bateman BT, Gray KJ, Huybrechts KF, Hernández-Díaz S. Mansour O, et al. Am J Obstet Gynecol. 2024 Aug;231(2):250.e1-250.e16. doi: 10.1016/j.ajog.2023.12.020. Epub 2023 Dec 19. Am J Obstet Gynecol. 2024. PMID: 38128861 Free PMC article.
BACKGROUND: Medication use during pregnancy has increased in the United States despite the lack of safety data for many medications. ...Future research should focus on anti-infectives with high utilization and limited level of evidence on safety for use durin …
BACKGROUND: Medication use during pregnancy has increased in the United States despite the lack of safety data for many medica …
Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes.
Masarwe S, Shvartsur R, Hadar E, Betesh-Abay B, Peleg N, Azab AN. Masarwe S, et al. Clin Nurs Res. 2023 May;32(4):705-711. doi: 10.1177/10547738231159062. Epub 2023 Mar 13. Clin Nurs Res. 2023. PMID: 36912091
This study examines the association between ondansetron treatment during pregnancy and birth defects and adverse obstetric outcomes. ...Notwithstanding, additional prospectively designed research is needed to establish the safety of ondansetron treatme …
This study examines the association between ondansetron treatment during pregnancy and birth defects and adverse obstetric out …
Ondansetron and pregnancy: Understanding the data.
Kennedy D. Kennedy D. Obstet Med. 2016 Mar;9(1):28-33. doi: 10.1177/1753495X15621154. Epub 2015 Dec 23. Obstet Med. 2016. PMID: 27512487 Free PMC article. Review.
Despite several studies showing no clear benefits of ondansetron over other NVP treatments such as doxylamine, and the paucity of safety data, the off-label prescribing and use of ondansetron to treat NVP has increased significantly worldwide. Albeit based on …
Despite several studies showing no clear benefits of ondansetron over other NVP treatments such as doxylamine, and the paucity of …
Ondansetron use in early pregnancy and the risk of miscarriage.
Suarez EA, Boggess K, Engel SM, Stürmer T, Lund JL, Jonsson Funk M. Suarez EA, et al. Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):103-113. doi: 10.1002/pds.5143. Epub 2020 Oct 12. Pharmacoepidemiol Drug Saf. 2021. PMID: 33000871
BACKGROUND: Ondansetron is commonly used to treat nausea and vomiting in pregnancy despite inconclusive evidence of its safety. ...CONCLUSIONS: We did not observe an increase in the risk of miscarriage for pregnancies exposed to ondansetron vs c …
BACKGROUND: Ondansetron is commonly used to treat nausea and vomiting in pregnancy despite inconclusive evidence of its saf …
Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).
Damkier P, Kaplan YC, Shechtman S, Diav-Citrin O, Cassina M, Weber-Schoendorfer C. Damkier P, et al. Basic Clin Pharmacol Toxicol. 2021 Apr;128(4):579-582. doi: 10.1111/bcpt.13541. Epub 2020 Dec 16. Basic Clin Pharmacol Toxicol. 2021. PMID: 33275828
Ondansetron is an effective antiemetic that is being widely used as a second-line treatment option for severe nausea and vomiting of pregnancy in accordance with clinical guidelines. The safety of ondansetron during pregnancy has-following publi …
Ondansetron is an effective antiemetic that is being widely used as a second-line treatment option for severe nausea and vomiting of …
Ondansetron Use in Pregnancy.
Siminerio LL, Bodnar LM, Venkataramanan R, Caritis SN. Siminerio LL, et al. Obstet Gynecol. 2016 May;127(5):873-877. doi: 10.1097/AOG.0000000000001375. Obstet Gynecol. 2016. PMID: 27054931 Free PMC article.
An efficacious treatment used widely across the United States for both nausea and vomiting of pregnancy and hyperemesis gravidarum is ondansetron. Recent studies have provided conflicting findings on the safety of ondansetron during pregnancy. T …
An efficacious treatment used widely across the United States for both nausea and vomiting of pregnancy and hyperemesis gravidarum is …
76 results